Validity of skeletal muscle mass index measurements for assessing sarcopenia in patients with gynecological cancer

Abstract Background The current study investigated an optimal method for using CT scan in detection of low skeletal muscle mass quantity (SMQ). Methods In total, 82 consecutive patients with gynecological cancers were examined using computed tomography (CT) and dual-energy X-ray absorptiometry (DEXA...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of clinical oncology 2021-10, Vol.51 (10), p.1534-1540
Main Authors: Yamada, Ryutaro, Tsuruta, Tomohiko, Todo, Yukiharu, Kurosu, Hiroyuki, Minowa, Kaoru, Minobe, Shinichiro, Matsumiya, Hiroko, Kato, Hidenori, Mori, Yoichi, Osanai, Toshihisa
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The current study investigated an optimal method for using CT scan in detection of low skeletal muscle mass quantity (SMQ). Methods In total, 82 consecutive patients with gynecological cancers were examined using computed tomography (CT) and dual-energy X-ray absorptiometry (DEXA) before treatment. Low SMQ was defined as a DEXA-based skeletal muscle mass index (SMI) of
ISSN:1465-3621
1465-3621
DOI:10.1093/jjco/hyab116